Reimbursement

Important considerations for pharmacists to concerning the switch from a brand name biologic to a new biosimilar.

Health care organizations show support for proposed Medicare Part D rules that require direct and indirect remuneration fees to be included at the point-of-sale.

Use of optical coherence tomography as a guiding therapy for neovascular age-related macular degeneration resulted in an estimated accrued savings of $9 billion for the US government through Medicare.

Electronic prior authorization can reduce time to fill for specialty drugs.

Despite the benefits of oral oncolytics, high out-of-pocket costs could put treatment out of reach for patients with cancer.

A new report highlights the potential pitfalls of formulary exclusion lists used by pharmacy benefit managers.

The Centers for Medicare and Medicaid Services finalized a ruling that slashes reimbursement rates on drugs that qualify under the 340B program.

Significant novel drugs slated for review by the FDA in 2018.

Marc O’Connor, chief operating officer at Curant Health, discusses how pharmacists can improve adherence among patients with chronic diseases.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses the importance of a quick turnaround from patient referral to acceptance.

The average profit from cancer drugs administered by 340B hospitals was nearly 50% in 2015.

Marc O’Connor, chief operating officer at Curant Health, explains ways patient care models can reduce costs.

Multiple specialty pharmacy processes can delay the time-to-fill for specialty medications.

Patients with multiple sclerosis who eat healthy could reduce their risk of severe disability by 20%.

THC found to slow the process of neurodegeneration, which affects nearly half of all patients with HIV.

Patients with cancer and caregivers said that the internet helped them to make informed care-related decisions.

Medication histories taken by pharmacists and pharmacy technicians significantly reduced medication errors.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Pharmacy professionals must embrace a number of changes in technology.

Patients with a partner were nearly twice as likely to finish 6 months of chemotherapy for colon cancer.

Top news of the day from across the health care landscape.

Increasing collaboration among providers could improve medication adherence and patient outcomes.

Gaps in genome sequencing can lead to misdiagnosis for patients of non-European descent.

The National Association of Specialty Pharmacy plans to submit comments about proposed Medicare changes.

Customized technology may help specialty pharmacies drive adherence and patient outcomes.

Doubling Medicare sequester cuts could reduce access to lower-cost cancer treatment.

The efficacy and safety of an adalimumab biosimilar matched the reference products in switching studies treating plaque psoriasis and rheumatoid arthritis.

Marc O’Connor, chief operating officer, Curant Health, discusses the best ways for pharmacies to succeed in the shift to value-based care.